Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery

Phase I Safety and Feasibility Pilot Study of Same-Day Discharge After Video-Assisted Thoracoscopic Surgery (VATS) Anatomical Lung or Wedge Resection (VALUE Trial)

Phase I to evaluate the safety and feasibility of same-day discharge in selected participants undergoing minimally-invasive lung surgery and who receive an enhanced recovery pathway.

Inclusion Criteria:

• Signed or verbal informed consent by participant
• Male and female adults, age 18 and above
• Clinical stage I-II lung cancer (suspected, proven, unproven), or secondary pulmonary malignancy
• BMI < 35
• ECOG 0-1
• Eligible for surgery and lung cancer resection (FEV1 > 60%, DLCO > 60%)
• Elective VATS anatomic resection (segmentectomy or lobectomy), or wedge resection
• Capable caregiver for discharge home

Exclusion Criteria:

• Clinical stage III lung cancer
• Surgery requiring pneumonectomy
• Neoadjuvant therapy
• Active pregnancy or breastfeeding
• History of chronic pain syndromes
• History of chronic opioid use
• Concomitant major surgery indicated with current admission to hospital
• Anticipated intraoperative complication including conversion to thoracotomy, major bleeding requiring blood transfusion, extensive adhesiolysis, injury to mediastinal structures, airway injury, nerve injury (phrenic, recurrent)
• Need for epidural or patient-controlled intravenous analgesia
• Need for urinary catheter